Aug 24 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- US FDA AWARDS ORPHAN DRUG DESIGNATION TO PAXALISIB FOR MALIGNANT GLIOMA, INCLUDING DIPG
News: KZA Kazia Therapeutics Says U.S. FDA Awards Orphan Drug Designation To Paxalisib
Add to My Watchlist
What is My Watchlist?